Medibank is an insurance - specialty business based in Australia. Medibank shares (MPL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Medibank has a trailing 12-month revenue of around $7.9 billion. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Medibank, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for day trading
Our top pick for
Education & learning
Our top pick for
Low commission
| 52-week range | $3.2273 - $3.94 |
|---|---|
| 50-day moving average | $3.6958 |
| 200-day moving average | $3.6549 |
| Target price | $3.87 |
| PE ratio | 16.3913 |
| Dividend yield | $0.155 (3.82%) |
| Earnings per share (TTM) | $0.23 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$3.83
| 1 week (2024-07-18) | 2.13% |
|---|---|
| 1 month (2024-06-26) | 2.68% |
| 3 months (2024-04-26) | 7.58% |
| 6 months (2024-01-25) | 2.41% |
| 1 year (2023-07-26) | 10.37% |
|---|---|
| 2 years (2022-07-26) | 11.34% |
| 3 years (2021-07-26) | 15.36% |
| 5 years (2019-07-26) | 5.80% |
Valuing Medibank stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medibank's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medibank's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Medibank shares trade at around 16x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Medibank's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $966 million (£0.0 million).
The EBITDA is a measure of a Medibank's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $7.9 billion |
|---|---|
| Operating margin TTM | 12.18% |
| Gross profit TTM | $1.6 billion |
| Return on assets TTM | 15.24% |
| Return on equity TTM | 31.67% |
| Profit margin | 8.63% |
| Book value | 0.857 |
| Market capitalisation | $10.4 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medibank.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 20.86
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medibank's overall score of 20.86 (as at 12/31/2018) is pretty good – landing it in it in the 29th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Medibank is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.11/100
Medibank's environmental score of 3.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 10.91/100
Medibank's social score of 10.91 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Medibank is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.84/100
Medibank's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Medibank is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Medibank scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Medibank has, for the most part, managed to keep its nose clean.
Medibank Private Ltd was last rated for ESG on: 2019-01-01.
| Total ESG score | 20.86 |
|---|---|
| Total ESG percentile | 29.38 |
| Environmental score | 3.11 |
| Environmental score percentile | 1 |
| Social score | 10.91 |
| Social score percentile | 1 |
| Governance score | 8.84 |
| Governance score percentile | 1 |
| Level of controversy | 2 |
Dividend payout ratio: 1.58% of net profits
Recently Medibank has paid out, on average, around 1.58% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medibank shareholders could enjoy a 3.82% return on their shares, in the form of dividend payments. In Medibank's case, that would currently equate to about A$0.155 per share.
While Medibank's payout ratio might seem low, this can signify that Medibank is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 28 February 2024 (the "ex-dividend date").
Over the last 12 months, Medibank's shares have ranged in value from as little as $3.2273 up to $3.94. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Medibank's is 0.182. This would suggest that Medibank's shares are less volatile than average (for this exchange).
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. The company underwrites its health insurance products under the Medibank and ahm brands. Medibank Private Limited was founded in 1976 and is based in Docklands, Australia.
Looking to start investing? Here are our top 6 online trading platforms for total beginners in Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Find out the different ways you can invest in the S&P 500 index from Australia.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Looking to build your wealth? A guide on the investment accounts available in Australia.
A beginner's guide to options trading in Australia. Read the step-by-step process and compare brokers to start trading.
Learn how to find the cheapest brokerage fees and a range of flexible trading features when you buy and sell US shares.
Follow these tips to find the best share trading platform for you.
Learn everything you need to know in this easy to follow, step-by-step guide to buying shares in Australia.